Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Teva
Farmers Insurance
Daiichi Sankyo
McKesson
Express Scripts
UBS
McKinsey
Chubb

Generated: June 22, 2018

DrugPatentWatch Database Preview

RADIOGARDASE (PRUSSIAN BLUE) Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Radiogardase (prussian Blue), and when can generic versions of Radiogardase (prussian Blue) launch?

Radiogardase (prussian Blue) is a drug marketed by Heyl Chemisch and is included in one NDA.

The generic ingredient in RADIOGARDASE (PRUSSIAN BLUE) is ferric hexacyanoferrate(ii). There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ferric hexacyanoferrate(ii) profile page.
Summary for RADIOGARDASE (PRUSSIAN BLUE)
US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Clinical Trials: 1
DailyMed Link:RADIOGARDASE (PRUSSIAN BLUE) at DailyMed
Drug patent expirations by year for RADIOGARDASE (PRUSSIAN BLUE)
Pharmacology for RADIOGARDASE (PRUSSIAN BLUE)

US Patents and Regulatory Information for RADIOGARDASE (PRUSSIAN BLUE)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heyl Chemisch RADIOGARDASE (PRUSSIAN BLUE) ferric hexacyanoferrate(ii) CAPSULE;ORAL 021626-001 Oct 2, 2003 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cipla
Cantor Fitzgerald
QuintilesIMS
Deloitte
Julphar
Cerilliant
Fuji
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.